We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
2020-05-02
A report states that three-quarters of the roughly 230 nanopharmaceuticals in clinical development are for use as targeted cancer therapeutics.
2020-05-01
2020-04-30
